APA (7th ed.) Citation

Li, C., Zhang, J., Xue, M., Li, X., Han, F., Liu, X., . . . Chen, L. (2019). SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovascular diabetology, 18(1), 15-13. https://doi.org/10.1186/s12933-019-0816-2

Chicago Style (17th ed.) Citation

Li, Chenguang, et al. "SGLT2 Inhibition with Empagliflozin Attenuates Myocardial Oxidative Stress and Fibrosis in Diabetic Mice Heart." Cardiovascular Diabetology 18, no. 1 (2019): 15-13. https://doi.org/10.1186/s12933-019-0816-2.

MLA (9th ed.) Citation

Li, Chenguang, et al. "SGLT2 Inhibition with Empagliflozin Attenuates Myocardial Oxidative Stress and Fibrosis in Diabetic Mice Heart." Cardiovascular Diabetology, vol. 18, no. 1, 2019, pp. 15-13, https://doi.org/10.1186/s12933-019-0816-2.